Acadian Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,560,770
| Closed | -$1.63M | – | 2308 |
|
|
2024
Q2 | $1.63M | Sell |
4,560,770
-382,490
| -8% | -$137K | 0.01% | 834 |
|
|
2024
Q1 | $3.31M | Buy |
4,943,260
+192,385
| +4% | +$129K | 0.01% | 556 |
|
|
2023
Q4 | $2.58M | Buy |
4,750,875
+1,823,106
| +62% | +$990K | 0.01% | 609 |
|
|
2023
Q3 | $1.75M | Buy |
2,927,769
+105,789
| +4% | +$63.3K | 0.01% | 722 |
|
|
2023
Q2 | $3.67M | Buy |
2,821,980
+2,353,741
| +503% | +$3.06M | 0.02% | 538 |
|
|
2023
Q1 | $822K | Buy |
+468,239
| New | +$822K | ﹤0.01% | 929 |
|
|
2021
Q2 | – | Sell |
-9,925
| Closed | -$124K | – | 2190 |
|
|
2021
Q1 | $124K | Buy |
9,925
+3,240
| +48% | +$40.5K | ﹤0.01% | 1622 |
|
|
2020
Q4 | $104K | Buy |
+6,685
| New | +$104K | ﹤0.01% | 1739 |
|
|
2017
Q4 | – | Sell |
-44,862
| Closed | -$673K | – | 1666 |
|
|
2017
Q3 | $673K | Buy |
+44,862
| New | +$673K | ﹤0.01% | 741 |
|